Stocks
Amicus Therapeutics (FOLD) EV/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EV/EBITDA | ? | -15.2 | -0.79 | -1.73 | 104.2 | 85.1 | 85.3 | |
| Changes by years, y/y, % | -38% | -95% | +117% | -6 137% | -18% | |||
Amicus Therapeutics. EV/EBITDA
Amicus Therapeutics. EV/EBITDA, changes, %
Amicus Therapeutics (FOLD) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2024Q4 | FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | LTM ? | |||
| EV/EBITDA | ? | 102.4 | 50.4 | 59.8 | 44.0 | 85.3 | 85.3 | |
| Changes by years, y/y, % | -6 038% | -2 092% | -1 412% | -112% | -17% | |||
| Changes by quarters, q/q, % | -127% | -51% | +19% | -26% | +94% | |||
